| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |